Trials / Active Not Recruiting
Active Not RecruitingNCT07179653
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Chronic Hepatitis B Patients
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Grand Theravac Life Sciences (Nanjing) Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study was to evaluate the efficacy and safety of TVAX- 008 injection in a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II clinical trial in subjects with HBSAg levels of 0.05 to 100 IU/mL, including CHB patients previously treated with siRNA/ASO drugs and treatment-naive HBV infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TVAX-008 | TVAX-008 |
| DRUG | Placebo | Placebo |
Timeline
- Start date
- 2025-01-22
- Primary completion
- 2025-12-01
- Completion
- 2026-12-01
- First posted
- 2025-09-18
- Last updated
- 2025-09-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07179653. Inclusion in this directory is not an endorsement.